Search Patents
  • Generating pharming alerts with reduced false positives
    Patent number: 9621582
    Abstract: A technique for informing an Internet site operator of potential pharming attacks includes generating pharming alerts based on mismatches between a set of expected IP addresses and IP addresses obtained from DNS servers on the Internet and filtering the generated alerts based on circumstances surrounding the generated pharming alerts. Filtering the alerts blocks less suspect pharming alerts while allowing more suspect ones to pass to the site operator, reducing the rate of false positives and better enabling the operator to focus on alerts that may present actual threats.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: April 11, 2017
    Assignee: EMC IP Holding Company LLC
    Inventor: Mirit Hirsh
  • Anti-pharming in wireless computer networks at pre-IP state
    Patent number: 8191143
    Abstract: Anti-pharming techniques in wireless computer networks at pre-IP state are disclosed. A user computer connecting to a wireless computer network may include an anti-pharming module configured to monitor data communications to and from a wireless access point of the wireless computer network. The anti-pharming module may be configured to determine if data communication going in a direction from the wireless access point to the user computer originated from a wireless station rather than a server configured to dynamically provide network addresses to computers connecting to the wireless computer network. The wireless station may be deemed a malicious computer perpetrating a pharming attack when it originated the data communication and is responding to a request to obtain network address previously sent by the user computer.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: May 29, 2012
    Assignee: Trend Micro Incorporated
    Inventors: Kun-Shan Lin, Pei-Chun Yao, Chia-Chi Chang
  • METHOD AND SYSTEM FOR DNS-BASED ANTI-PHARMING
    Publication number: 20080060054
    Abstract: A method and system for discovering domain name system (DNS) pharming, comprising: obtaining an answer to a question from two different sources; comparing the answers; determining that the technology is not suspect when the answer is the same; and determining that the technology is suspect when the answer is different.
    Type: Application
    Filed: September 4, 2007
    Publication date: March 6, 2008
    Inventor: Manoj SRIVASTAVA
  • CLIENT SIDE PROTECTION AGAINST DRIVE-BY PHARMING VIA REFERRER CHECKING
    Publication number: 20080281983
    Abstract: HTTP requests initiated from a web browser of a client computer system are proxied prior to release to a router, such as a home router. HTTP requests identifying a referrer URL corresponding to routable, public IP address and a target URL corresponding to a non-routable, private IP address are determined to be indicative of a drive-by pharming attack, and are blocked from sending to the router. HTTP requests not identifying a referrer URL corresponding to a routable, public IP address and a target URL corresponding to a non-routable, private IP address, the HTTP request are not determined to be indicative of a drive-by pharming attack, and are released for sending to the router. In some embodiments, an HTTP response received in response to a released HTTP request is proxied prior to release to the web browser. An HTTP response having content of type text/html or script is modified as indicated to prevent malicious activity and released to the web browser.
    Type: Application
    Filed: May 9, 2007
    Publication date: November 13, 2008
    Inventors: Shaun Cooley, Rowan Trollope
  • Methods for Protecting from Pharming and Spyware Using an Enhanced Password Manager
    Publication number: 20090208020
    Abstract: Methods implemented by enhanced Password Manager for protecting against Pharming and Spyware comprising matching a saved record with certificate of website and withholding saved record's data if a match is not found. Further comprising, scrambling of retrieved data with a scrambling key wherein said key is synchronized with website.
    Type: Application
    Filed: February 1, 2009
    Publication date: August 20, 2009
    Inventor: Amiram Grynberg
  • Client side protection against drive-by pharming via referrer checking
    Patent number: 7827311
    Abstract: HTTP requests initiated from a web browser of a client computer system are proxied prior to release to a router, such as a home router. HTTP requests identifying a referrer URL corresponding to routable, public IP address and a target URL corresponding to a non-routable, private IP address are determined to be indicative of a drive-by pharming attack, and are blocked from sending to the router. HTTP requests not identifying a referrer URL corresponding to a routable, public IP address and a target URL corresponding to a non-routable, private IP address, the HTTP request are not determined to be indicative of a drive-by pharming attack, and are released for sending to the router. In some embodiments, an HTTP response received in response to a released HTTP request is proxied prior to release to the web browser. An HTTP response having content of type text/html or script is modified as indicated to prevent malicious activity and released to the web browser.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: November 2, 2010
    Assignee: Symantec Corporation
    Inventors: Shaun Cooley, Rowan Trollope
  • Autonomous system-based phishing and pharming detection
    Patent number: 8245304
    Abstract: Methods for detecting an attempt to perpetrate fraud on a user utilizing a client-supplied link and a client-supplied IP address from a user computer. The method ascertains a first autonomous system number (“first AS number”) from the client-supplied IP address and a second autonomous system number (“second AS number”) from the client-supplied link. If the first AS number and the second AS number are not AS group peers, a pharming attempt is detected. Alternatively or additionally, the method includes analyzing a content of a webpage that is accessed using the client-supplied IP address to ascertain an identity of an apparent owner of the webpage and ascertaining a third autonomous system number (“third AS number”) from the identity of the apparent owner of the webpage. If the first AS number and the third AS number are not AS group peers, a phishing attempt is detected.
    Type: Grant
    Filed: June 26, 2006
    Date of Patent: August 14, 2012
    Assignee: Trend Micro Incorporated
    Inventors: Chao-Yu Chen, Tse-Min Chen
  • System and Method of Mobile Anti-Pharming and Improving Two Factor Usage
    Publication number: 20070174630
    Abstract: A variant of phishing involves subverting an Internet access point, often used for mobile computing. Malware can route user requests for bank websites into a phisher's private network, with fake bank websites (pharming). The user can have a “mobile password” at the bank. When she connects from an access point, she sends a hash, found from the password, starting at some position in it. The bank returns a hash, found from the same password, starting at another position in it. Each can verify the other. We protect both from a man in the middle attack. By hashing a web page and the mobile password, and inserting the hash into the page that is sent, the recipient can verify that the page is untampered. We use an anonymizer, external to the access point. A user pre-establishes a password with the anonymizer. At the access point, she and the anonymizer use a zero knowledge protocol to verify each other, based on the password. Then, the password encrypts communication between them.
    Type: Application
    Filed: February 18, 2006
    Publication date: July 26, 2007
    Inventors: Marvin Shannon, Wesley Boudville
  • Protecting computer users from online frauds
    Patent number: 7958555
    Abstract: Protecting computer users from online frauds, such as phishing and pharming. A client computer may include a page signature extractor and a policy enforcer. The page signature extractor may encode a web page to generate its signature, which may be provided to a remote server computer for comparison with signatures of phishing pages. The client computer and the server computer may communicate using the DNS protocol. The policy enforcer may perform one or more predetermined actions when a match is found. Examples of such actions include replacing the web page with a blocking page, displaying a warning message, or both. The policy enforcer may be configured to determine if the web page is part of a phishing or pharming attack by comparing the URL of the web page to URLs of legitimate web pages.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: June 7, 2011
    Assignee: Trend Micro Incorporated
    Inventors: Chih Sheng Chen, Shr-An Su, Yi-Chan Hung
  • Treatment and prevention of pre-eclampsia
    Publication number: 20200390872
    Abstract: The present invention relates to the field of medicine, specifically to the prevention and treatment of pre-eclampsia.
    Type: Application
    Filed: February 28, 2019
    Publication date: December 17, 2020
    Applicant: Pharming Intellectual Property B.V.
    Inventors: Sijmen de Vries, Bruno Giannetti
  • C1 inhibitor produced in the milk of transgenic mammals
    Publication number: 20050223416
    Abstract: The invention provides transgenic nonhuman mammals expressing C1 inhibitor in their milk. The C1 inhibitor is useful in treating patients with hereditary angioedema or patients requiring immunosuppression.
    Type: Application
    Filed: March 22, 2005
    Publication date: October 6, 2005
    Applicant: Pharming Intellectual Property B.V.
    Inventors: Johannes Nuijens, Henricus Van Veen, Frank Pieper, Joris Heus
  • Homologous recombination in mammalian cells
    Patent number: 5721367
    Abstract: The invention relates to methods for intracellularly producing DNA segments by homologous recombination of smaller overlapping DNA fragments and transgenic mammalian cells and transgenic non-human mammals produced by such methods.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: February 24, 1998
    Assignee: Pharming B.V.
    Inventors: Robert M. Kay, Anton Berns, Paul Krimpenfort, Frank Pieper, Rein Strijker
  • Treatment of pompe's disease
    Publication number: 20040081645
    Abstract: The invention provides methods of treating Pompe's disease using human acid alpha glucosidase. A preferred treatment regime comprises administering greater than 10 mg/kg body weight per week to a patient.
    Type: Application
    Filed: June 30, 2003
    Publication date: April 29, 2004
    Applicants: Genzyme Corporation, Pharming Intellectual Property B.V.
    Inventors: Johannes B.M.M. Van Bree, Edna H.G. Venneker, David P. Meeker
  • Isolation of lactoferrin from milk
    Patent number: 5919913
    Abstract: The invention provides methods for purification of human lactoferrin from milk, especially milk of nonhuman species, and for separation of human lactoferrin from undesired macromolecular species present in the milk, including separation from nonhuman lactoferrin species.
    Type: Grant
    Filed: March 9, 1995
    Date of Patent: July 6, 1999
    Assignee: Pharming B.V.
    Inventors: Jan H. Nuyens, Harry H. Van Veen
  • Isolation of lactoferrin from milk
    Patent number: 5861491
    Abstract: The invention provides methods for purification of human lactoferrin from milk, especially milk of nonhuman species, and for separation of human lactoferrin from undesired macromolecular species present in the milk, including separation from nonhuman lactoferrin species.
    Type: Grant
    Filed: October 16, 1996
    Date of Patent: January 19, 1999
    Assignee: Pharming B.V.
    Inventors: Jan H Nuijens, Harry H Van Veen
  • Useful properties of human lactoferrin and variants thereof
    Patent number: 6333311
    Abstract: The invention provides compositions containing human lactoferrin, or lactoferrin variants deleted for one or more arginine residues in the amino-terminal region of the protein (i.e., in the first basic cluster), and methods of using the compositions. The human lactoferrin, or lactoferrin variants are useful for treatment of human diseases and conditions, including inflamation.
    Type: Grant
    Filed: February 2, 1998
    Date of Patent: December 25, 2001
    Assignee: Pharming
    Inventors: Jan Nuijens, Patrick van Berkel
  • Expression of proteins in milk
    Publication number: 20040250300
    Abstract: This invention relates to the production of recombinant proteins in mammals' milk. Particularly, this invention relates to an expression system which when transgenically incorporated into a mammal permits the female species of that mammal to produce the desired recombinant protein in or along with its milk. This invention also relates to the transgenic mammal that produces the desired recombinant product in its milk.
    Type: Application
    Filed: March 2, 2004
    Publication date: December 9, 2004
    Applicant: Pharming B.V.
    Inventors: Harry Meade, Nils Lonberg
  • TREATMENT OF BLEEDING WITH LOW HALF-LIFE FIBRINOGEN
    Publication number: 20110263503
    Abstract: The invention provides low-half life fibrinogen as a result of recombinant expression or enzymatic and chemical removal. The low-half life fibrinogen is useful in treating or effecting prophylaxis of bleeding particularly in situations of an acute nature in which a high initial dose and rapid decline to normal or below normal levels is desirable.
    Type: Application
    Filed: April 29, 2009
    Publication date: October 27, 2011
    Applicant: Pharming Intellectual Property B.V.
    Inventors: Frank Pieper, Anurag Relan, Erik Jordahl Forsberg
  • Production of collagen in the milk of transgenic mammals
    Publication number: 20050172342
    Abstract: The invention provides transgenic nonhuman mammals capable secreting exogenous procollagen or collagen into their milk. The mammals are healthy and capable of producing procollagen or collagen at high levels, usually in trimeric form. Suitable transgenes for incorporation into the mammals are also provided.
    Type: Application
    Filed: December 18, 2003
    Publication date: August 4, 2005
    Applicants: Pharming B.V., Cohesion Technologies, Inc.
    Inventors: Costas Karatzas, Frank Pieper, Ineke De Wit, Richard Berg, Gerard Platenburg, Paul Toman
  • Isolation of lactoferrin from milk
    Patent number: 5849885
    Abstract: The invention provides methods for purification of human lactoferrin from milk, especially milk of nonhuman species, and for separation of human lactoferrin from undesired macromolecular species present in the milk, including separation from nonhuman lactoferrin species.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 15, 1998
    Assignee: Gene Pharming Europe B.V.
    Inventors: Jan H. Nuyens, Harry H. Van Veen
Narrow Results

Filter by US Classification